Inder Paul Singh, MD

New technologies and a proactive mindset are transforming how glaucoma is diagnosed and treated—and redefining what “controlled” really means.

A novel vitrectomy device shows promising safety and efficacy in the targeted removal of symptomatic vitreous opacities in pseudophakic eyes

Inder Paul Singh, MD, speaks to the potential of artificial intelligence (AI) in the management of the glaucoma disease state as well as the current challenges of drug delivery in treating patients with glaucoma.

Paul Singh, MD, shares key takeaways from the roundtable meeting and other surgical pearls to enhance phacoemulsification outcomes.

Paul Singh, MD, demonstrates the advantages of cutting-edge phacoemulsification technologies through surgical videos, showcasing their capability to prevent post-occlusion surges and maintain optimal chamber stability.

Paul Singh, MD, utilizes surgical videos to illustrate the dynamics of a post-occlusion surge and highlights how it can result in anterior chamber instability and posterior capsule rupture.

The cataract surgery process continues to become more refined.

Numerous studies have shown that adherence declines with more complex regimens of more than 1 or 2 bottles.

Speed the return to baseline visual acuity—and make your patients happy.

Innovation, change has dominated the glaucoma specialty over the years.

Alternative method ensures lens is set properly during cataract surgery